107 related articles for article (PubMed ID: 2858709)
21. Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
Lancet; 1998 Sep; 352(9132):930-42. PubMed ID: 9752815
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant treatment for early breast cancer: the Ludwig breast cancer studies.
Goldhirsch A; Gelber R
NCI Monogr; 1986; (1):55-70. PubMed ID: 3774016
[TBL] [Abstract][Full Text] [Related]
23. Tamoxifen reduces the risk of contralateral breast cancer in premenopausal women: Results from a controlled randomised trial.
Alkner S; Bendahl PO; Fernö M; Nordenskjöld B; Rydén L;
Eur J Cancer; 2009 Sep; 45(14):2496-502. PubMed ID: 19535242
[TBL] [Abstract][Full Text] [Related]
24. Adjuvant tamoxifen versus tamoxifen plus CMF in the treatment of early breast cancer in Greece. Fifteen-year results of a randomised prospective trial and the potential risks of the antioestrogen.
Vorgias G; Koukouras D; Tzoracoeleftherakis E; Paleogianni V; Androulakis J
Anticancer Res; 2000; 20(5C):3849-54. PubMed ID: 11268466
[TBL] [Abstract][Full Text] [Related]
25. Dissemination of adjuvant multiagent chemotherapy and tamoxifen for breast cancer in the United States using estrogen receptor information: 1975-1999.
Mariotto AB; Feuer EJ; Harlan LC; Abrams J
J Natl Cancer Inst Monogr; 2006; (36):7-15. PubMed ID: 17032888
[TBL] [Abstract][Full Text] [Related]
26. Benefit and projected cost-effectiveness of anastrozole versus tamoxifen as initial adjuvant therapy for patients with early-stage estrogen receptor-positive breast cancer.
Hillner BE
Cancer; 2004 Sep; 101(6):1311-22. PubMed ID: 15368322
[TBL] [Abstract][Full Text] [Related]
27. Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer: update of study BIG 1-98.
Coates AS; Keshaviah A; Thürlimann B; Mouridsen H; Mauriac L; Forbes JF; Paridaens R; Castiglione-Gertsch M; Gelber RD; Colleoni M; Láng I; Del Mastro L; Smith I; Chirgwin J; Nogaret JM; Pienkowski T; Wardley A; Jakobsen EH; Price KN; Goldhirsch A
J Clin Oncol; 2007 Feb; 25(5):486-92. PubMed ID: 17200148
[TBL] [Abstract][Full Text] [Related]
28. One year of adjuvant tamoxifen compared with chemotherapy and tamoxifen in postmenopausal patients with stage II breast cancer.
Ejlertsen B; Jensen MB; Elversang J; Rasmussen BB; Andersson M; Andersen J; Nielsen DL; Cold S; Mouridsen HT
Eur J Cancer; 2013 Sep; 49(14):2986-94. PubMed ID: 23756360
[TBL] [Abstract][Full Text] [Related]
29. Adjuvant tamoxifen treatment of elderly women with stage II breast cancer. A double-blind comparison with placebo.
Cummings FJ; Gray R; Davis TE; Tormey DC; Harris JE; Falkson G; Arseneau J
Ann Intern Med; 1985 Sep; 103(3):324-9. PubMed ID: 3896085
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant tamoxifen for operable carcinoma of the breast: report of clinical trial by the Christie Hospital and Holt Radium Institute.
Ribeiro G; Palmer MK
Br Med J (Clin Res Ed); 1983 Mar; 286(6368):827-30. PubMed ID: 6403101
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant endocrine therapy of breast cancer--a controlled clinical trial of oestrogen and anti-oestrogen: preliminary results of the Copenhagen breast cancer trials.
Palshof T; Mouridsen HT; Daehnfeldt JL
Recent Results Cancer Res; 1980; 71():185-9. PubMed ID: 6988914
[TBL] [Abstract][Full Text] [Related]
32. The Stockholm trial on adjuvant tamoxifen in early breast cancer. Correlation between estrogen receptor level and treatment effect.
Rutqvist LE; Cedermark B; Glas U; Johansson H; Nordenskjöld B; Skoog L; Somell A; Theve T; Friberg S; Askergren J
Breast Cancer Res Treat; 1987 Dec; 10(3):255-66. PubMed ID: 3328986
[TBL] [Abstract][Full Text] [Related]
33. The relationship between histological grade, oestrogen receptor status, events and survival at 8 years in the NATO ('Nolvadex') trial.
Singh L; Wilson AJ; Baum M; Whimster WF; Birch IH; Jackson IM; Lowrey C; Palmer MK
Br J Cancer; 1988 Jun; 57(6):612-4. PubMed ID: 3044433
[TBL] [Abstract][Full Text] [Related]
34. A randomised trial of tamoxifen versus tamoxifen with aminoglutethimide in post-menopausal women with advanced breast cancer.
Milsted R; Habeshaw T; Kaye S; Sangster G; Macbeth F; Campbell-Ferguson J; Smith D; Calman K
Cancer Chemother Pharmacol; 1985; 14(3):272-3. PubMed ID: 3888433
[TBL] [Abstract][Full Text] [Related]
35. The Christie hospital adjuvant tamoxifen trial--status at 10 years.
Ribeiro G; Swindell R
Br J Cancer; 1988 Jun; 57(6):601-3. PubMed ID: 3044432
[TBL] [Abstract][Full Text] [Related]
36. A comparison of two doses of tamoxifen (Nolvadex) in postmenopausal women with advanced breast cancer: 10 mg bd versus 20 mg bd.
Bratherton DG; Brown CH; Buchanan R; Hall V; Kingsley Pillers EM; Wheeler TK; Williams CJ
Br J Cancer; 1984 Aug; 50(2):199-205. PubMed ID: 6380554
[TBL] [Abstract][Full Text] [Related]
37. The Christie Hospital tamoxifen (Nolvadex) adjuvant trial for operable breast carcinoma--7-yr results.
Ribeiro G; Swindell R
Eur J Cancer Clin Oncol; 1985 Aug; 21(8):897-900. PubMed ID: 3899666
[TBL] [Abstract][Full Text] [Related]
38. Prospective randomised trial of tamoxifen versus surgery in elderly patients with breast cancer.
Gazet JC; Markopoulos C; Ford HT; Coombes RC; Bland JM; Dixon RC
Lancet; 1988 Mar; 1(8587):679-81. PubMed ID: 2895214
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant tamoxifen in early breast cancer: occurrence of new primary cancers.
Fornander T; Rutqvist LE; Cedermark B; Glas U; Mattsson A; Silfverswärd C; Skoog L; Somell A; Theve T; Wilking N
Lancet; 1989 Jan; 1(8630):117-20. PubMed ID: 2563046
[TBL] [Abstract][Full Text] [Related]
40. Fatal myocardial infarction in the Scottish adjuvant tamoxifen trial. The Scottish Breast Cancer Committee.
McDonald CC; Stewart HJ
BMJ; 1991 Aug; 303(6800):435-7. PubMed ID: 1912833
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
